NCT00681798View on ClinicalTrials.gov

Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Pancreatic Cancer
Interventions
DRUG

Vandetanib

100mg/300mg

Trial Locations (2)

Unknown

Research Site, Sankt Gallen

Research Site, Bellinzona

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00681798 - Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma | Biotech Hunter | Biotech Hunter